Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moderna, Inc. (MRNA) vs Revolution Medicines, Inc. (RVMD)

Moderna, Inc. and Revolution Medicines, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $78.8B against $42.9B — 1.8× the size. Revolution Medicines, Inc. grew revenue faster over the last twelve months: −8.81% against −27.6%. Revolution Medicines, Inc. has the higher net margin (0.00% vs −141.4%) and the higher return on invested capital (0.00% vs −93.5%). Across the 18 metrics below, Moderna, Inc. leads on 10 and Revolution Medicines, Inc. on 8.

Valuation

Metric MRNA RVMD Biotechnology median
P/E n/m n/m 7.88
P/S 35.53 1,606.35 11.47
P/B 11.71 16.59 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 33.49 1,498.51 10.73
Earnings yield (4.02%) (4.30%) (28.84%)
Free cash flow yield (1.57%) (2.85%) (23.03%)

Profitability

Metric MRNA RVMD Biotechnology median
Gross margin 23.38% 35.06% 65.16%
Operating margin (149.01%) 0.00% 0.00%
Net margin (141.43%) 0.00% 0.00%
Free cash flow margin (55.83%) 0.00% 0.00%
Return on equity (39.00%) (79.09%) (57.72%)
Return on assets (27.43%) (52.37%) (49.22%)
Return on invested capital (93.47%) 0.00% 0.00%

Growth

Metric MRNA RVMD Biotechnology median
Revenue growth (TTM) (27.62%) (8.81%) 5.64%
EPS growth (last fiscal year) 21.77% (66.20%) —
Revenue growth, 5-year CAGR 19.34% (10.50%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRNA RVMD Biotechnology median
Debt to equity 0.09 0.40 0.00
Current ratio 2.29 11.38 4.73
Net debt to EBITDA 1.77 1.47 0.96

Dividend

Metric MRNA RVMD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MRNA RVMD Biotechnology median
Market cap 78.77b 42.88b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack